Caldera Medical develops minimally invasive medical devices for treating stress urinary incontinence, pelvic organ prolapse, and hysteroscopic tissue removal, enabling physicians to provide safe, effective care for women's pelvic health. The company pairs its product portfolio with physician education and support programs to ensure proper use and continuous improvement. Additionally, Caldera Medical runs a global humanitarian initiative aimed at treating and educating one million women worldwide by 2027.
Funding
Funding not disclosed
Founders
Product
Problem
Women with stress urinary incontinence, pelvic organ prolapse, polyps, or fibroids often face limited treatment options that require invasive surgery, long recovery times, and significant discomfort, leading to reduced quality of life and social isolation.
Solution
Caldera Medical offers a portfolio of minimally invasive devices that enable surgeons to treat stress urinary incontinence, pelvic organ prolapse, and hysteroscopic tissue conditions such as polyps and fibroids through small incisions or transvaginal approaches. The devices are designed for ease of use, allowing procedures to be completed more quickly with less tissue trauma and faster patient recovery. Caldera supports physicians with comprehensive training programs and a feedback loop that incorporates surgeon input to continuously refine product performance and safety. By reducing procedural invasiveness, the solutions help women regain confidence and return to active lifestyles sooner. The company also runs a global humanitarian program aimed at delivering these treatments and related education to underserved women worldwide, targeting one million treated patients by 2027.
Target Audience
Primary customers are gynecologic surgeons, urogynecologists, and interventional gynecologists who perform minimally invasive pelvic procedures, as well as hospitals and clinics seeking less invasive treatment options for female pelvic health.
Features
- Small‑incision, transvaginal delivery systems for stress urinary incontinence and pelvic organ prolapse that minimize operative time and postoperative pain
- Hysteroscopic tissue removal devices optimized for precise excision of polyps and fibroids with reduced uterine trauma
- Integrated physician education platform offering hands‑on training, procedural guidelines, and ongoing support
- Real‑time device feedback mechanisms that capture surgeon performance data to inform product improvements
- Scalable humanitarian deployment model that includes device donation, on‑site training, and community education initiatives